Found: 24
Select item for more details and to access through your institution.
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 2, p. 511, doi. 10.1007/s00432-018-2819-x
- By:
- Publication type:
- Article
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 3, p. 2031, doi. 10.1007/s10072-021-05561-z
- By:
- Publication type:
- Article
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments.
- Published in:
- Tumori Journal, 2024, v. 110, n. 5, p. 309, doi. 10.1177/03008916241231687
- By:
- Publication type:
- Article
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 4, p. 199, doi. 10.1007/PL00006687
- By:
- Publication type:
- Article
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 4, p. 182, doi. 10.1159/000497211
- By:
- Publication type:
- Article
Sporotrichoid cutaneous infection by Mycobacterium abscessus.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 4, p. e291, doi. 10.1111/ijd.12215
- By:
- Publication type:
- Article
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1980, doi. 10.3390/cancers15071980
- By:
- Publication type:
- Article
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III).
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2466, doi. 10.3390/cancers13102466
- By:
- Publication type:
- Article
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 223, doi. 10.3390/cancers11020223
- By:
- Publication type:
- Article
Doxifluridine as Palliative Treatment in Advanced Gastric and Pancreatic Cancer Patients.
- Published in:
- Oncology, 1996, v. 53, n. 1, p. 54, doi. 10.1159/000227535
- By:
- Publication type:
- Article
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 967, doi. 10.1007/s40261-018-0690-9
- By:
- Publication type:
- Article
A Zero-Order Flood Damage Model for Regional-Scale Quick Assessments.
- Published in:
- Water (20734441), 2021, v. 13, n. 9, p. 1292, doi. 10.3390/w13091292
- By:
- Publication type:
- Article
Cutaneous melanoma in adolescents and young adults.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-116
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-137
- By:
- Publication type:
- Article
THE CONCEPT OF SUSCEPTIBILITY AS RAPID TOOL FOR LAND'S HYDRAULIC PROTECTION AND GOVERNANCE: The case study of Apulia region (Italy).
- Published in:
- Geophysical Research Abstracts, 2019, v. 21, p. 1
- By:
- Publication type:
- Article
Characteristics of Real-World Patients with High-Risk BRAF<sup>V600E/K</sup>-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
- Published in:
- Cancer Management & Research, 2023, v. 15, p. 1271, doi. 10.2147/CMAR.S423970
- By:
- Publication type:
- Article
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 789, doi. 10.1007/s11523-021-00850-1
- By:
- Publication type:
- Article
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 4, p. 529, doi. 10.1007/s11523-021-00819-0
- By:
- Publication type:
- Article
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1336566
- By:
- Publication type:
- Article
Gut Microbiota, Metabolome, and Body Composition Signatures of Response to Therapy in Patients with Advanced Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11611, doi. 10.3390/ijms241411611
- By:
- Publication type:
- Article
Investigating the role of immunotherapy in advanced/ recurrent female genital tract melanoma: a preliminary experience.
- Published in:
- Journal of Gynecologic Oncology, 2019, v. 30, n. 6, p. 1, doi. 10.3802/jgo.2019.30.e94
- By:
- Publication type:
- Article
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12964-020-00601-1
- By:
- Publication type:
- Article